Back
Structure Therapeutics Stock Price Chart
Former Chicago Pit Trader Exposes Shocking Trading Advantage:
See How to Target Up to 383% OVERNIGHT
Buy
69
GPCR
Structure Therapeutics
Last Price:
40.65
Seasonality Move:
120.41%
7 Day Trial
ALL ACCESS PASS
$
7
Hedge fund manager warns about the market ahead
Free book prepares you for the coming uncertainty in the stock market- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GPCR is experiencing slight buying pressure.
Structure Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 37.97 | Buy |
| 20-day SMA: | 38.78 | Buy |
| 50-day SMA: | 38.13 | Buy |
| 200-day SMA: | 41.63 | Sell |
| 8-day EMA: | 38.73 | Buy |
| 20-day EMA: | 38.3 | Buy |
| 50-day EMA: | 38.64 | Buy |
| 200-day EMA: | 39.64 | Buy |
Structure Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.22 | Buy |
| Relative Strength Index (14 RSI): | 58.7 | Buy |
| Chaikin Money Flow: | 178568 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (35.68 - 40.3) | Buy |
| Bollinger Bands (100): | (34.6 - 45.02) | Buy |
Structure Therapeutics Technical Analysis
| Aug 30 | Sep 3 | Sep 4 | Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | Sep | |||||||||
| 30 | 03 | 04 | 05 | 06 | 09 | 10 | 11 | 12 | 13 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Structure Therapeutics Stock
Is Structure Therapeutics Stock a Buy?
- Structure Therapeutics share price is 40.84 while GPCR 8-day simple moving average is 37.97, which is a Buy signal.
- The stock price of GPCR is 40.84 while Structure Therapeutics 20-day SMA is 38.78, which makes it a Buy.
- Structure Therapeutics 50-day simple moving average is 38.13 while GPCR share price is 40.84, making it a Buy technically.
- GPCR stock price is 40.84 and Structure Therapeutics 200-day simple moving average is 41.63, creating a Sell signal.
GPCR Technical Analysis vs Fundamental Analysis
Buy
69
Structure Therapeutics (GPCR)
is a Buy
Is Structure Therapeutics a Buy or a Sell?
-
Structure Therapeutics stock is rated a Buy
The current Structure Therapeutics [GPCR] share price is $40.84. The Score for GPCR is 69, which is 38% above its historic median score of 50, and infers lower risk than normal.
Structure Therapeutics Stock Info
Market Cap:
2.34B
Price in USD:
40.84
Share Volume:
1.06M
Structure Therapeutics 52-Week Range
52-Week High:
75.02
52-Week Low:
26.61
Buy
69
Structure Therapeutics (GPCR)
is a Buy
Structure Therapeutics Share Price Forecast
-
What is the Structure Therapeutics stock price today?
The Structure Therapeutics stock price is 40.84 USD today. -
Will GPCR stock go up or go down?
Structure Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Structure Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Structure Therapeutics is not overvalued.
Is Structure Therapeutics Stock a Buy?
- Structure Therapeutics share price is 40.84 while GPCR 8-day exponential moving average is 38.73, which is a Buy signal.
- The stock price of GPCR is 40.84 while Structure Therapeutics 20-day EMA is 38.30, which makes it a Buy.
- Structure Therapeutics 50-day exponential moving average is 38.64 while GPCR share price is 40.84, making it a Buy technically.
- GPCR stock price is 40.84 and Structure Therapeutics 200-day simple moving average is 39.64, creating a Buy signal.
Fundamental Analysis of Structure Therapeutics
Is Structure Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.08 per share, an increase this year of $0.08 per share, and an increase next year of $0.08 per share.
Technical Analysis of Structure Therapeutics
Should I short Structure Therapeutics stock?
- GPCR Moving Average Covergence Divergence (MACD) indicator is 0.22, suggesting Structure Therapeutics is a Buy
- Structure Therapeutics Relative Strength Index (RSI) is 58.7, which suggest Structure Therapeutics is overbought
- The Bollinger Bands (25) for Structure Therapeutics is (35.68 - 40.3), which suggest Structure Therapeutics is a Buy
- The Bollinger Bands (100) for Structure Therapeutics is (34.6 - 45.02), which suggest Structure Therapeutics is a Buy
* Structure Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.